首页> 外国专利> PROBIOTIC COMPOUND ON THE BASIS OF ENTEROCOCCUS FAECIUM STRAIN L-3 FOR MEDICAL-PROPHYLACTIC MEANS AND METHOD OF PRODUCTION THEREOF

PROBIOTIC COMPOUND ON THE BASIS OF ENTEROCOCCUS FAECIUM STRAIN L-3 FOR MEDICAL-PROPHYLACTIC MEANS AND METHOD OF PRODUCTION THEREOF

机译:基于肠球菌粪便菌株L-3的药用组合物的益生化合物及其生产方法

摘要

The inventive probiotic composition based on the enterococcus strain relates to novel treatment means for preventing and curing bacterial and viral infections and dysbacteriosis of mucosa and skin and can be used for pharmacology, medicine and cosmetology. Said invention also relates to microbiology, in particular to the strains of the bacteria-enterococcus used in medical and food biotechnology. Said strains exhibit high-adhesive properties and pronounced antagonistic properties with respect to gram-negative coliform bacteria and gram-positive bacteria and fungus and also resistance to the action of extremal factors. The invention can be carried out in any region of the globe using acting pharmacological and food productions and microbiological and biotechnological laboratories . The production of the probiotic composition is ecologically safe and low waste. The inventive method consists in producing a probiotic composition based on a separated enterococcus strain and having a high antagonistic activity in relation to opportunistic and pathogenic microflora, and used for treatment means and curative food products. The invention, whose feasibility is proved by many clinical and laboratory tests, ensures the high efficiency of the inventive probiotic composition for preventing and curing various skin and mucosa inflammatory processes. The invention is successfully used for cosmetology and dermatology in the form of skin patches, cosmetic masks, medicinal powders, external ointments, and also for gastroenterology in the form of pills and pastilles for stomach, intestines, oral mucosa etc. The inventive method for producing the probiotic composition is universal, reliable and ecologically safe.
机译:基于肠球菌菌株的本发明的益生菌组合物涉及用于预防和治疗粘膜和皮肤的细菌和病毒感染以及菌群失调的新型治疗手段,并且可以用于药理,医学和美容。所述发明还涉及微生物学,特别是涉及在医学和食品生物技术中使用的细菌-肠球菌的菌株。所述菌株相对于革兰氏阴性大肠菌和革兰氏阳性菌和真菌表现出高粘附性和明显的拮抗性,并且对极端因子的作用具有抗性。可以使用代理药理和食品生产以及微生物和生物技术实验室在全球任何地区进行本发明。益生菌组合物的生产在生态上安全且浪费少。本发明的方法在于生产基于分离的肠球菌菌株的益生菌组合物,其相对于机会和致病菌群具有高拮抗活性,并用于治疗手段和治疗性食品。通过许多临床和实验室测试证明了本发明的可行性,该发明确保了本发明益生菌组合物用于预防和治疗各种皮肤和粘膜炎性过程的高效。本发明以皮肤贴剂,化妆品面膜,药用粉末,外用药膏的形式成功地用于美容和皮肤病学,并且以用于胃,肠,口腔粘膜等的药丸和锭剂的形式用于胃肠病学。本发明的生产方法益生菌成分具有通用性,可靠性和生态安全性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号